Literature DB >> 7123405

The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy.

G J Vink, J Moodley.   

Abstract

The effects on the fetus of the acute lowering of blood pressure in maternal hypertension with dihydralazine 6.25 mg were studied in 27 Black patients with diastolic blood pressures of 110 mmHg or more. The fetus was found to be growth-retarded in 13 of the 14 cases in which fetal heart rate decelerations coincided with a fall in maternal blood pressure. Only 2 of the 13 fetuses without heart rate changes were growth-retarded (P less than 0.001). Continuous fetal heart monitoring during the lowering of the blood pressure helped in recognizing the 'comprised' fetus if this had been missed by other observations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7123405

Source DB:  PubMed          Journal:  S Afr Med J


  3 in total

Review 1.  Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors:  P M Kyle; C W Redman
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 2.  Focused Update on Pharmacologic Management of Hypertensive Emergencies.

Authors:  Kristin Watson; Rachael Broscious; Sandeep Devabhakthuni; Zachary R Noel
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

3.  Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.

Authors:  Laura A Magee; Chris Cham; Elizabeth J Waterman; Arne Ohlsson; Peter von Dadelszen
Journal:  BMJ       Date:  2003-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.